Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats

Journal of Pharmacological Sciences

Volumn 105, Issue 1, 2007, Pages 94-102

  Dengiz, Gunnur Ozbakis ^a   Odabasoglu, Fehmi ^b   Halici, Zekai ^b   Cadirci, Elif ^b   Suleyman, Halis ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzyme; Gastroprotective effect; Indomethacin; Montelukast; Myeloperoxidase

Indexed keywords

FAMOTIDINE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INDOMETACIN; LANSOPRAZOLE; MONTELUKAST; MYELOPEROXIDASE; RANITIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; RAT; STOMACH INJURY; STOMACH PROTECTION; STOMACH ULCER;

EID: 34748903399     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0070122     Document Type: Article

References (56)

1. Spahn JD, Leung DYM. The role of glucocorticoids in the management of asthma. Allergy Asthma Proc. 1996;17:341-350.
2. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. New Engl J Med. 1999;340:197-206.
3. Wenzel SE. Leukotriene receptor antagonists and related compounds. Can Respir J. 1999;6:189-193.
4. Spector SL, Smith LJ, Glass M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4-receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med. 1994;150:618-623.
5. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment ofchronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158:1213-1220.
6. Wallace JL, McKnight GW, Keenan CM, Byles NI, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology. 1990;98:1178-1186.
7. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil dependent process. Am J Physiol. 1990;259:462-467.
8. Peskar BM. Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacine in the rat stomach. Gastroenterology. 1991;100:619-626.
9. Damon M, Chavis C, Godard P, Michel FB, Crastes de Paulet A. Purification and mass spectrometry identification of leukotriene D4 synthesized by human alveolar macrophages. Biochem Biophys Res Commun. 1983;111:518-524.
10. Williams JD, Czop JK, Austen KF. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 1984;132:3034-3040.
11. Konturek SJ, Brozozowski T, Drozdowicz D, Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats. Dig Dis Sci. 1988;33:806-813.
12. Gyomber E, Vattay P, Szabo S, Rainsford KD. Effect of lipoxigenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic lesions in ulcer models in the rat. J Gastroenterol Hepatol. 1996;11:922-927.
13. Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol. 2001;15:691-703.
14. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Int J Tissue React. 1998;20:3-15.
15. Milller T. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanism. Am J Physiol. 1983;235:601-623.
16. Takeuchi K, Okada M, Ebara S, Osano H. Increased microvascular permeability and lesion formation during gastric hypermotility caused by indomethacin and 2-deoxy-D-glucose in rat. J Clin Gastroenterol. 1990;12:76-84.
17. Whittle BJ. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol. 2003;17:301-313.
18. Pohle T, Brzozowski T, Becker JC, Van Der Voort IR, Markman A, Konturek SJ, et al. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther. 2001;15:677-687.
19. Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S, et al. Role of active oxygen, lipid peroxidation and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut. 1993;34:732-737.
20. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915-7922.
21. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet. 1994;344:721-724.
22. Mizoguchi H, Ogawa Y, Kanatsu K, Tanaka A, Kato S, Takeuchi K. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol. 2001;16:1112-1119.
23. Takeuchi K, Yasuhiro T, Asada Y, Sugawa Y. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats. Digestion. 1998;59:298-307.
24. CCAC. Guide to the care and use of experimental animals, Vol I, 2nd Ed. Canadian Council on Animal Care. Ottawa: Bradda Printing Services Inc.; 1993.
25. Guidobono F, Pagani F, Ticozzi C, Sbilia V, Pecile A, Netti C. Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol.1997;120:581-586.
26. Halici M, Odabasoglu F, Suleyman H, Cakir A, Aslan A, Bayir Y. Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. Phytomedicine. 2005;12:656-662.
27. Qarawi AA, Abdel-Rahman H, Ali BH, Mousa HM, El-Mougy SA. The ameliorative effect of dates (Phoenix dactylifera L.) on ethanol-induced gastric ulcer in rats. J Ethnopharmacol. 2005;98:313-317.
28. Farzin D, Attarzadeh M. Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat. Eur J Pharmacol. 2000;404:169-174.
29. Wagner KA, Nandi J, King RL, Levine RA. Effects of nonsteroidal antiinflammatory drugs on ulcerogenesis and gastric secretion in pylorus-ligated rat. Dig Dis Sci. 1995;40:134-140.
30. Sun Y, Larry WO, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
31. Aebi H. Catalase. Medhods Enzymol. 1984;105:121-126.
32. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484-490.
33. Habig WH, Jakoby WB. Assays for differentiation glutathione-S- transferase. Methods Enzymol. 1981;77:398-405.
34. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982:78;206-209.
35. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryls groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205.
36. Sener G, Kapucu C, Cetinel S, Cikler E, Ayanoglu G. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Prostaglandins Leukot Essent Fatty Acids. 2005;72:1-11.
37. Whittle BJR. Temporal relationship between COX inhibition, as measured by prostaglandin biosynthesis and the gastrointestinal damage induced by indomethacin in rat. Gastroenterology. 1981;80:94-98.
38. Tegeder I, Neupert W, Guhring H, Geislinger G. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. J Pharmacol Exp Ther. 2000; 292:1161-1168.
39. Smith SM, Kvietys PR. Gastric ulcers: role of oxygen radicals. Crit Care Med. 1988;16:892-898.
40. Das D, Bandyopadhyay D, Bhattacharjee M, Banerjee RK. Hydroxyl radical is the major cousative factor in stress-induced gastric ulceration. Free Radic Biol Med. 1997;23:8-18.
41. Naito Y, Yoshikawa T, Yoshida N, Kondo M. Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci. 1998;43:30-34.
42. Elliot SN, Wallace JL. Neutrophil-mediated gastrointestinal injury. Can J Gastroenterol. 1998;12:559-568.
43. Basiviredy J, Jacob M, Ramamoorthy P, Pulimood AB, Balasubramanian KA. Indomethacin-induced free radical-mediated changes in the intestinal brush border membranes. Biochem Pharmacol. 2003;65:683-695.
44. Bayir Y, Odabasoglu F, Cakir A, Aslan A, Suleyman H, Halici M, et al. The inhibition of gastric mucosal lesion, oxidative stress and neutrophil- infiltration in rats by the lichen constituent diffractaic acid. Phytomedicine. 2006;13:584-590.
45. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, et al. Gastroprotective and antioxidant effects of usnic acid on indomethacine-induced gastric ulcer in rats. J Ethnopharmacol. 2006;103:59-65.
46. El-Missiry MA, El-Sayed IH, Othman AI. Protection by metal complexes with SOD-mimetic activity against oxidative gastric injury induced by indomethacin and ethanol in rats. Ann Clin Biochem. 2001;38:694-700.
47. Kaleli S, Akkayab A, Akdogan M, Gultekin F. The effects of different treatments on prolidase and antioxidant enzyme activities in patients with bronchial asthma. Environ Toxicol Pharmacol. 2006;22:35-39.
48. Chen G, Kamal M, Hannon R, Warner TD. Regulation of cyclooxygenase gene expression in rat smooth muscle cells by catalase. Biochem Pharmacol. 1998;55:1621-1631.
49. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family; regulation of GST and the contribution of the isoenzymes to cancer chemoprovention and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445-600.
50. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-760.
51. Shacter E, Lopez RL, Pati S. Inhibition of myeloperoxidase-H2O2-Cl-system of neutrophils by indometahcin and other nonsteroidal anti-inflammatory drugs. Biochem Pharmacol. 1991; 41:975-984.
52. Kabasakal L, Sener G, Cetinel S, Contuk G, Gedik N, Yegen BC. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids. 2005;72:431-440.
53. Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yegen BC. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns. 2005;31:587-596.
54. Sener G, Sehirli O, Cetinel S, Ercan F, Yuksel M, Gedik N, et al. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor Blocker montelukast. Prostaglandins Leukot Essent Fatty Acids. 2005;73:453-462.
55. Fitzpatrick LR, Sakurai K, Le T. Indomethacin-induced gastric antral damage in hamsters: are neutrophils involved? Aliment Pharmacol Ther. 1999;13:195-202.
56. Murakami K, Okajima K, Harada N, Isobe H, Liu W, Johno M, et al. Pleunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Aliment Pharmacol Ther. 1999;13:521-530.